Evidence map›Paper›PMID 34805638›Full record

ArticleKidney international reports2021

Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.

Andrea G Cogal, Jennifer Arroyo, Ronak Jagdeep Shah, Kalina J Reese, Brenna N Walton, Laura M Reynolds, Gabrielle N Kennedy, Barbara M Seide, Sarah R Senum, Michelle Baum and 12 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The Role of Altered Mineral Metabolism in Kidney Stone Disease: Is Vitamin D the Key?American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  5. Article
  6. The effects of elevated phosphate on the kidney - damaging the gatekeeper.Pflugers Archiv : European journal of physiology · 2026
    Review
  7. Observational
  8. Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 4 countries.

Andrea G CogalDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Jennifer ArroyoDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Ronak Jagdeep ShahDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Kalina J ReeseDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
Brenna N WaltonDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
Laura M ReynoldsDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
Gabrielle N KennedyDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
Barbara M SeideDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Sarah R SenumDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Michelle BaumChildren's Hospital, Boston, Massachusetts, USA.
Stephen B EricksonDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Sujatha JagadeeshMediscan Systems, Mylapore, Chennai, Tamil Nadu, India.
Neveen A SolimanDepartment of Pediatrics, Center of Pediatric Nephrology and Transplantation, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
David S GoldfarbNephrology Division, New York University Langone Health and New York University School of Medicine, New York, New York, USA.
Lada Beara-LasicNephrology Division, New York University Langone Health and New York University School of Medicine, New York, New York, USA.
Vidar O EdvardssonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Runolfur PalssonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Dawn S MillinerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
David J SasDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
John C LieskeDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Peter C HarrisDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Investigators of the Rare Kidney Stone Consortium
Mayo Clinic · USNYU Langone Health · USBoston Children's Hospital · USCairo University · EGFetal Care Research Foundation · INNational University Hospital of Iceland · ISUniversity of Iceland · IS

Funding

Primary HyperoxaluriaU54DK083908 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2009 to 2018
$12.3M
KIDNEY DISEASES RESEARCH TRAINING PROGRAMT32DK007013 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 1986 to 2023
$3.7M
Facilitating personalized medicine of monogenic stone patients by genetic characterizationR21TR003174 · NCATS · MAYO CLINIC ROCHESTER · PI HARRIS, PETER C., LIESKE, JOHN C · 2020 to 2021
$437k
NCATS NIH HHS R21 TR003174NIDDK NIH HHS T32 DK007013NIDDK NIH HHS U54 DK083908
6 · The paper itself

Abstract

introductionBecause of phenotypic overlap between monogenic urinary stone diseases (USD), gene-specific analyses can result in missed diagnoses. We used targeted next generation sequencing (tNGS), including known and candidate monogenic USD genes, to analyze suspected primary hyperoxaluria (PH) or Dent disease (DD) patients genetically unresolved (negative; N) after Sanger analysis of the known genes. Cohorts consisted of 285 PH (PHN) and 59 DD (DDN) families.

methodsVariants were assessed using disease-specific and population databases plus variant assessment tools and categorized using the American College of Medical Genetics (ACMG) guidelines. Prior Sanger analysis identified 47 novel PH or DD gene pathogenic variants.

resultsScreening by tNGS revealed pathogenic variants in 14 known monogenic USD genes, accounting for 45 families (13.1%), 27 biallelic and 18 monoallelic, including 1 family with a copy number variant (CNV). Recurrent genes included the following:

conclusionOverall, in patients suspected of DD or PH, 23.9% and 7.3% of cases, respectively, were caused by pathogenic variants in other genes. This study shows the value of a tNGS screening approach to increase the diagnosis of monogenic USD, which can optimize therapies and facilitate enrollment in clinical trials.

Indexed as

Dent diseasekidney stonesmolecular geneticsmonogenicprimary hyperoxaluria

Identifiers

PMID34805638
PMCPMC8589729
OpenAlexW3200127018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.